AR062145A1 - Metoods y composiciones para aumentar el tropismo tisular de vectores adenovirales recombinantes - Google Patents
Metoods y composiciones para aumentar el tropismo tisular de vectores adenovirales recombinantesInfo
- Publication number
- AR062145A1 AR062145A1 ARP070103361A ARP070103361A AR062145A1 AR 062145 A1 AR062145 A1 AR 062145A1 AR P070103361 A ARP070103361 A AR P070103361A AR P070103361 A ARP070103361 A AR P070103361A AR 062145 A1 AR062145 A1 AR 062145A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- tropism
- metoods
- tissular
- increase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10345—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10371—Demonstrated in vivo effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6009—Vectors comprising as targeting moiety peptide derived from defined protein from viruses dsDNA viruses
- C12N2810/6018—Adenoviridae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Geophysics And Detection Of Objects (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Métodos que permiten la preparacion de vectores adenovirales con tropismo modificado. También se revelan composiciones que comprenden dichos vectores y métodos de uso de los mismos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83398506P | 2006-07-28 | 2006-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR062145A1 true AR062145A1 (es) | 2008-10-15 |
Family
ID=38981845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070103361A AR062145A1 (es) | 2006-07-28 | 2007-07-30 | Metoods y composiciones para aumentar el tropismo tisular de vectores adenovirales recombinantes |
Country Status (12)
Country | Link |
---|---|
US (1) | US8163544B2 (es) |
EP (1) | EP2059602A4 (es) |
JP (1) | JP2009544303A (es) |
KR (1) | KR20090038910A (es) |
CN (1) | CN101849012A (es) |
AR (1) | AR062145A1 (es) |
AU (1) | AU2007278887A1 (es) |
BR (1) | BRPI0714932A2 (es) |
CA (1) | CA2658805A1 (es) |
MX (1) | MX2009000898A (es) |
TW (1) | TW200829273A (es) |
WO (1) | WO2008012682A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090038910A (ko) * | 2006-07-28 | 2009-04-21 | 커먼웰쓰 사이언티픽 앤드 인더스트리얼 리서치 오가니제이션 | 재조합 아데노바이러스 벡터의 조직 향성을 증가시키기 위한 방법 및 조성물 |
US20100150959A1 (en) * | 2008-12-15 | 2010-06-17 | Vectogen Pty Ltd. | PCV 2-Based Methods and Compositions for the Treatment of Pigs |
US8865182B2 (en) * | 2009-07-31 | 2014-10-21 | Paxvax, Inc. | Adenoviral-based vectors |
CN109563518A (zh) * | 2016-05-12 | 2019-04-02 | 巴伊沃爱普有限公司 | 来自植物的用于经典猪瘟的疫苗组合物及其制造方法 |
CN107267469B (zh) * | 2017-08-22 | 2020-06-16 | 广州医科大学附属第一医院 | 纤毛蛋白嵌合型重组人b型腺病毒及其制备方法 |
CN112625095B (zh) * | 2021-01-13 | 2023-01-03 | 武汉科前生物股份有限公司 | 一种猪轮状病毒重组蛋白以及表达该蛋白的重组腺病毒和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7232899B2 (en) * | 1996-09-25 | 2007-06-19 | The Scripps Research Institute | Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
AUPO856097A0 (en) * | 1997-08-14 | 1997-09-04 | Commonwealth Scientific And Industrial Research Organisation | Vector |
US6492343B1 (en) * | 1998-04-15 | 2002-12-10 | University Of Saskatchewan | Porcine adenovirus type 3 genome |
AU4070499A (en) | 1998-04-30 | 1999-11-16 | Cornell Research Foundation Inc. | Adenoviral vectors with tandem fiber proteins |
EP1191105A1 (en) | 2000-09-25 | 2002-03-27 | Galapagos Genomics B.V. | Gene delivery vectors provided with a tissue tropism for T-lymphocytes |
CA2410665C (en) | 2000-05-31 | 2017-11-07 | University Of Saskatchewan | Modified bovine adenovirus having altered tropism |
US20030219899A1 (en) * | 2001-04-17 | 2003-11-27 | Nikolay Korokhov | Mosaic adenoviral vectors |
KR20090038910A (ko) * | 2006-07-28 | 2009-04-21 | 커먼웰쓰 사이언티픽 앤드 인더스트리얼 리서치 오가니제이션 | 재조합 아데노바이러스 벡터의 조직 향성을 증가시키기 위한 방법 및 조성물 |
-
2007
- 2007-07-27 KR KR1020097003405A patent/KR20090038910A/ko not_active Application Discontinuation
- 2007-07-27 MX MX2009000898A patent/MX2009000898A/es unknown
- 2007-07-27 EP EP07804942A patent/EP2059602A4/en not_active Withdrawn
- 2007-07-27 JP JP2009521375A patent/JP2009544303A/ja active Pending
- 2007-07-27 AU AU2007278887A patent/AU2007278887A1/en not_active Abandoned
- 2007-07-27 CN CN200780026689A patent/CN101849012A/zh active Pending
- 2007-07-27 US US12/373,772 patent/US8163544B2/en not_active Expired - Fee Related
- 2007-07-27 BR BRPI0714932-8A patent/BRPI0714932A2/pt not_active IP Right Cessation
- 2007-07-27 CA CA002658805A patent/CA2658805A1/en not_active Abandoned
- 2007-07-27 WO PCT/IB2007/002710 patent/WO2008012682A2/en active Application Filing
- 2007-07-30 TW TW096127865A patent/TW200829273A/zh unknown
- 2007-07-30 AR ARP070103361A patent/AR062145A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007278887A1 (en) | 2008-01-31 |
TW200829273A (en) | 2008-07-16 |
KR20090038910A (ko) | 2009-04-21 |
BRPI0714932A2 (pt) | 2013-05-21 |
CN101849012A (zh) | 2010-09-29 |
JP2009544303A (ja) | 2009-12-17 |
CA2658805A1 (en) | 2008-01-31 |
WO2008012682A2 (en) | 2008-01-31 |
WO2008012682A3 (en) | 2008-06-19 |
MX2009000898A (es) | 2009-02-04 |
US20100104600A1 (en) | 2010-04-29 |
US8163544B2 (en) | 2012-04-24 |
EP2059602A4 (en) | 2010-06-23 |
EP2059602A2 (en) | 2009-05-20 |
WO2008012682A8 (en) | 2009-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6630181A2 (es) | Composiciones y métodos para uso de anticuerpos terapéuticos de lrp6( proteina relacionada con lipoproteínas de baja densidad 6) | |
BRPI0708344B8 (pt) | vetores adenovirais quiméricos e composição imunogênica | |
AR057237A1 (es) | Metodos y composiciones para actuar sobre la poliubiquitina | |
CR20150088A (es) | Anticuerpos anti-notch1 nrr | |
CR20160206A (es) | Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento C5 | |
CO6491076A2 (es) | Formulaciones de toxinas botulínica libre de albúmina | |
BRPI1008061A8 (pt) | polipeptídeos recombinantes estendidos e composições compreendendo os mesmos | |
CO6430468A2 (es) | Anticuerpos anti-fcrh5 e inmunoconjugados y métodos de uso | |
AR066042A1 (es) | Moleculas y metodos para modular la proteina convertasa-subtilisina /quexina tipo 9 (pcsk9) | |
BRPI0810863A2 (pt) | Uso de hidrolisados de proteína para estabilizar formulações de detergente de metaloprotease. | |
HN2006011218A (es) | Composiciones de tigeciclina y métodos de preparación | |
BRPI0811871A2 (pt) | Composições agroquímicas ácidas bioativas e uso das mesmas | |
ECSP077316A (es) | Compuestos imidazo-3-il-amina bicíclicos sustituidos | |
CL2011000301A1 (es) | Compuestos derivados de purina con actividad inmunomoduladora; composición farmacéutica que los comprende; y uso de ellos en el tratamiento de enfermedades alérgicas, rinitis alérgica, asma, enfermedades infecciosas y cáncer. | |
CL2008001879A1 (es) | Compuestos derivados de isaxolinas-naftalen-carboamida; y el uso de los compuestos en el control de plagas de invertebrados en animales. | |
CR20110640A (es) | Derivados de amiloide p sérico/de suero y su preparación y uso | |
AR062145A1 (es) | Metoods y composiciones para aumentar el tropismo tisular de vectores adenovirales recombinantes | |
BRPI0813000A2 (pt) | Composições terapêuticas e uso das mesmas | |
EA201390254A1 (ru) | Модифицированные полипептиды релаксина и их применение | |
BRPI0606506A2 (pt) | polipeptìdeos de yersinia spp. e métodos de uso | |
ECSP11011344A (es) | Nuevos anticuerpos anti-?5?1 y sus usos | |
CR20110034A (es) | Peptidos de señalizacion de la crkl | |
ECSP088743A (es) | Anticuerpos para egfl7 y métodos para su uso | |
EA201290541A1 (ru) | Модифицированные бычьи соматотропиновые полипептиды и их применение | |
CL2012000508A1 (es) | Composicion para la aplicacion en cultivos agricolas al aire libre o invernaderos que comprende zeolita, y aditivos; uso de la composicion para aumentar el rendimiento de los cultivos agricolas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |